Alnylam Pharmaceuticals (ALNY) EBT Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,460.35% |
| Dec 31, 2025 | 144.47% |
| Sep 30, 2025 | 358.20% |
| Jun 30, 2025 | -216.63% |
| Mar 31, 2025 | 96.28% |
| Dec 31, 2024 | -40.87% |
| Sep 30, 2024 | -172.09% |
| Jun 30, 2024 | 95.93% |
| Mar 31, 2024 | 63.11% |
| Dec 31, 2023 | 33.49% |
| Sep 30, 2023 | 137.13% |
| Jun 30, 2023 | 0.17% |
| Mar 31, 2023 | 27.99% |
| Dec 31, 2022 | 20.47% |
| Sep 30, 2022 | -98.76% |
| Jun 30, 2022 | -45.85% |
| Mar 31, 2022 | -20.11% |
| Dec 31, 2021 | -6.86% |
| Sep 30, 2021 | 19.10% |
| Jun 30, 2021 | -5.86% |
| Mar 31, 2021 | -9.71% |
| Dec 31, 2020 | 11.93% |
| Sep 30, 2020 | -20.83% |
| Jun 30, 2020 | 18.59% |
| Mar 31, 2020 | -0.24% |
| Dec 31, 2019 | -31.03% |
| Sep 30, 2019 | 14.67% |
| Jun 30, 2019 | -33.67% |
| Mar 31, 2019 | -28.27% |
| Dec 31, 2018 | -48.41% |
| Sep 30, 2018 | -99.16% |
| Jun 30, 2018 | -38.05% |
| Mar 31, 2018 | -31.68% |
| Dec 31, 2017 | -25.60% |
| Sep 30, 2017 | -17.67% |
| Jun 30, 2017 | -31.39% |
| Mar 31, 2017 | -4.19% |
| Dec 31, 2016 | -24.82% |
| Sep 30, 2016 | -36.05% |
| Jun 30, 2016 | -26.32% |
| Mar 31, 2016 | -101.09% |
| Dec 31, 2015 | -108.65% |
| Sep 30, 2015 | -74.84% |
| Jun 30, 2015 | -60.74% |
| Mar 31, 2015 | 80.95% |
| Dec 31, 2014 | -48.21% |
| Sep 30, 2014 | -37.45% |
| Jun 30, 2014 | -110.84% |
| Mar 31, 2014 | -2,707.45% |
| Dec 31, 2013 | -167.22% |
| Sep 30, 2013 | -63.86% |
| Jun 30, 2013 | -62.50% |
| Mar 31, 2013 | 15.77% |
| Dec 31, 2012 | 1.07% |
| Sep 30, 2012 | -47.33% |
| Jun 30, 2012 | 6.28% |
| Mar 31, 2012 | 30.19% |
| Dec 31, 2011 | 763.97% |
| Sep 30, 2011 | -41.85% |
| Jun 30, 2011 | 6.98% |
| Mar 31, 2011 | -32.34% |
| Dec 31, 2010 | 20.98% |
| Sep 30, 2010 | 4.39% |
| Jun 30, 2010 | 31.81% |